The Safety of 52 Weeks of Oral DHEA Therapy for Postmenopausal Women

    May 2009 in “ Maturitas ”
    Mary Panjari, Robin Jean Bell, Fiona Jane, Jenny Adams, Corallee Morrow, Susan Ruth Davis
    Image of study
    TLDR Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.
    In a study from 2009 involving 93 postmenopausal women over a 52-week period, a daily oral dose of 50 mg DHEA was tested for safety and its impact on sexual function, lipid profile, insulin-glucose homeostasis, and the endometrium. The study concluded that DHEA did not significantly affect blood lipids, insulin resistance, or the endometrium, although androgenic side effects like acne and increased facial hair were observed in the DHEA group. No cases of voice deepening or alopecia were reported. The study suggested that DHEA does not have metabolic benefits or adverse effects, challenging the idea of DHEA as an "anti-ageing" supplement for postmenopausal women, but also noted that the duration may have been too short to confirm endometrial safety, and the study was not sufficiently powered to definitively assess this endpoint.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 58 results

    Similar Research

    5 / 1000+ results
      Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman

      research Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman

      November 2022 in “The Journal of Clinical Endocrinology and Metabolism”
      Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.
      An Updated Overview of Polycystic Ovary Syndrome

      research An Updated Overview of Polycystic Ovary Syndrome

      1 citations, June 2019 in “Innovare journal of medical sciences”
      Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.